A Roundtable Conversation on Career Decisions for Pharmacists

Recently, Ken Perez, Healthcare IT, marketing & policy consultant and former Vice President of Healthcare Policy and Government Affairs for Omnicell, Inc. moderated a round table conversation with three pharmacy leaders - including interestingly two sisters - who have pursued different paths during their pharmacy career journeys. 

The panel included:

Nicolle Rychlick, Director of Advisory Services at Premier, Inc.

Janelle Rychlick, Medical Science Liaison Oncology at Novartis Oncology 

Nilesh Desai, Chief Pharmacy Officer for Baptist Health System

Its our hope that their experiences and insight might provide you with valuable information when determining what is the right path for your career. 

Latest Videos
View all Videos
Executive Insights
Feb 25, 2025
Hinnah Farooqi serves as the Director of Pharmacy at New York Presbyterian in Queens, a diverse hospital with 500 beds. She discusses the hospital's efforts to improve efficiency and patient safety by using more automation, like RFID technology called Intelligard. Hinnah also emphasizes teamwork with the central sterile team and the hospital's focus on developing leaders and improving management skills through partnerships and internal programs.
Feb 25, 2025

Valerie Hoffman is the Associate Marketing Director at Long Grove Pharmaceuticals. Valerie prioritizes drug safety and aims to enhance it through clear, distinctive labeling. She also emphasizes open communication in leadership and works to build strong customer relationships. 

Executive Insights
Feb 10, 2025

Mark Saxon, the CEO of Safecor Health, discusses the company's strategic plans for 2025, emphasizing their commitment to unit dose drug repackaging and error-free medication delivery. Mark highlights the importance of cultural change and core values such as care, commitment, and excellence in leadership. He expresses excitement about tackling healthcare challenges, cherishes family traditions, and is looking forward to a successful 2025.